Lumos Pharma, Inc. / Estimates

Fiscal Year	Revenue	Net income	Net margin	Free cash flow	FCF margin
2023	€1.77M +34.7%	-€29.32M +9.6%	-1,659.4% +3.8 pp	-€26.79M +16.9%	-1,516.1% +2.3 pp
2022	€1.31M +562.2%	-€26.76M +2.1%	-2,039.5% +110 pp	-€22.92M -10.2%	-1,746.7% +110 pp
2021	€198.16K +36.9%	-€26.22M +437.3%	-13,230.4% -99 pp	-€25.52M +29.0%	-12,877.4% +7.9 pp
2020	€144.74K -82.1%	-€4.88M -86.8%	-3,370.8% +12 pp	-€19.79M -24.0%	-13,670.8% -100 pp
2019	€806.41K -22.4%	-€37.04M -19.8%	-4,592.8% -1.5 pp	-€26.02M -20.4%	-3,227.0% -0.82 pp
2018	€1.04M +209.2%	-€46.17M -25.5%	-4,444.0% +140 pp	-€32.68M -21.4%	-3,145.3% +92 pp
2017	€336.00K -88.9%	-€61.99M -15.5%	-18,449.0% -160 pp	-€41.56M -24.3%	-12,368.7% -110 pp
2016	€3.04M -90.2%	-€73.37M +110.9%	-2,415.1% -23 pp	-€54.88M +217.0%	-1,806.6% -18 pp
2015	€31.14M -78.2%	-€34.79M -139.3%	-111.7% -1.7 pp	-€17.31M -118.1%	-55.6% -1.2 pp
2014	€142.97M +15,083.0%	€88.62M -429.9%	62.0% +29 pp	€95.43M -553.4%	66.7% +23 pp
2013	€941.67K -35.2%	-€26.86M +33.7%	-2,852.7% -15 pp	-€21.05M +27.6%	-2,235.3% -11 pp
2012	€1.45M -9.9%	-€20.09M +28.9%	-1,382.4% -4.2 pp	-€16.50M +51.2%	-1,135.0% -4.6 pp
2011	€1.61M -10.0%	-€15.58M +11.6%	-966.2% -1.9 pp	-€10.91M +22.5%	-676.7% -1.8 pp
2010	€1.79M +122.6%	-€13.97M +71.7%	-779.8% +2.3 pp	-€8.91M +33.6%	-497.3% +3.3 pp
2009	€804.69K +47.6%	-€8.13M +3.1%	-1,010.9% +4.4 pp	-€6.67M -8.5%	-828.4% +5.1 pp
2008	€545.36K	-€7.89M	-1,447.4%	-€7.29M	-1,336.2%